Autologous Concentrate Bone Marrow Cell Therapy for Ischemic Cardiomyopathy Unsuitable for Revascularization: Feasibility Study | Zendy

AI Assistant Blog Pricing

Open Access

Autologous Concentrate Bone Marrow Cell Therapy for Ischemic Cardiomyopathy Unsuitable for Revascularization: Feasibility Study

Author(s) -

Ospedale San Raffaele

Publication year - 2016

Publication title -

journal of cardiology and current research

Language(s) - Uncategorized

Resource type - Journals

ISSN - 2373-4396

DOI - 10.15406/jccr.2016.05.00163

Subject(s) - medicine , ischemic cardiomyopathy , cardiology , cardiomyopathy , revascularization , bone marrow , surgery , heart failure , myocardial infarction , ejection fraction

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.